Key result
Inhaled nitric oxide linked to ~89% response in refractory cerebral vasospasm after aneurysm rupture.
Why the study?
Inhaled nitric oxide may replenish the endothelial nitric oxide deficiency underlying symptomatic cerebral vasospasm after subarachnoid hemorrhage from ruptured cerebral aneurysms, but clinical data remain limited.
Does inhaled nitric oxide therapy improve regression of symptomatic cerebral vasospasm and cerebral perfusion in patients in the acute period of non-traumatic subarachnoid hemorrhage due to ruptured cerebral aneurysms?
Observational (n=9)
Open-label
No
Does inhaled nitric oxide therapy improve regression of symptomatic cerebral vasospasm and cerebral perfusion in patients in the acute period of non-traumatic subarachnoid hemorrhage due to ruptured cerebral aneurysms?
In a case series of 9 patients with aneurysmal subarachnoid hemorrhage, inhaled nitric oxide at 55–80 ppm safely promoted rapid regression of refractory symptomatic cerebral vasospasm in 8 patients without causing systemic hypotension or methemoglobinemia.
Answers are grounded in this paper and cite their sources.
Does not support practice change for refractory vasospasm; leaves open efficacy in randomized trials.
Introduction Symptomatic cerebral vasospasm (CVS) is one of the most severe complications of subarachnoid hemorrhage (SAH) due to ruptured cerebral aneurysms, leading to delayed cerebral ischemia. The pathogenesis of CVS is associated, among other factors, with a deficiency of the endothelial vasorelaxant factor — nitric oxide (NO). Administration of inhaled NO can replenish this deficit and help reduce the severity of CVS; however, clinical data remain limited. Aim To evaluate the feasibility of inhaled nitric oxide (iNO) therapy in patients with signs of symptomatic vasospasm in the acute period of non-traumatic SAH caused by ruptured cerebral aneurysms. Material and methods A case series was carried out involving 9 patients (5 women, 4 men; aged 35–74 years) admitted to the N.V. Sklifosovsky Research Institute for Emergency Medicine in 2022–2024 during the hyperacute period after cerebral aneurysm rupture. The main inclusion criterion was the development of symptomatic CVS resistant to standard therapy (calcium channel blockers, induced hypertension) for at least 1 hour. All the patients underwent microsurgical aneurysm clipping. Inhalation of NO was performed via a face mask using a “Tianox” device at a concentration of 55–80 ppm with FiO₂ 21% until regression of symptoms. Clinical neurological status, jugular venous oximetry, markers of oxidative stress (malondialdehyde (MDA), total antioxidant status (TAS)) and endogenous vascular regulation (nitric oxide metabolites (NOx), angiotensin-converting enzyme (ACE)), video-EEG monitoring and CT perfusion data were assessed. Results Inhalation therapy resulted in regression of symptomatic CVS in 8 of 9 patients, including complete neurological recovery in 5 patients. The mean time to symptom regression ranged from 3 to 21 hours. In 2 patients, premature discontinuation of therapy led to symptom recurrence, requiring resumption of inhalations. CT perfusion on day 7 revealed reversible focal cerebral perfusion deficits in 4 patients. No adverse effects (methemoglobinemia >3.5%, hypotension, toxic NO₂ concentrations) were recorded. Mortality (n=2) was due to extracranial complications. Conclusion Inhaled NO therapy in SAH patients with symptomatic CVS on spontaneous breathing is safe and potentially effective for rapid regression of neurological symptoms and improvement of cerebral perfusion.
No takes yet. Share an insight, caveat, or question.
Природов et al. (2026) conducted an observational in Symptomatic cerebral vasospasm after non-traumatic subarachnoid hemorrhage due to ruptured cerebral aneurysms (n=9). Inhaled nitric oxide (iNO) was evaluated on Regression of symptomatic cerebral vasospasm. Inhaled nitric oxide (55-80 ppm) resulted in regression of treatment-resistant symptomatic cerebral vasospasm in 8 of 9 patients within 3 to 21 hours after aneurysm rupture.
Synapse has enriched 10 related papers. Consider them for comparative context: